PubMed Central (PMC) Search Page
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 1999 | 29 |
| 2000 | 245 |
| 2001 | 140 |
| 2002 | 142 |
| 2003 | 176 |
| 2004 | 221 |
| 2005 | 371 |
| 2006 | 245 |
| 2007 | 161 |
| 2008 | 374 |
| 2009 | 246 |
| 2010 | 325 |
| 2011 | 279 |
| 2012 | 287 |
| 2013 | 220 |
| 2014 | 251 |
| 2015 | 199 |
| 2016 | 132 |
| 2017 | 135 |
| 2018 | 156 |
| 2019 | 155 |
| 2020 | 137 |
| 2021 | 118 |
| 2022 | 101 |
| 2023 | 155 |
| 2024 | 193 |
| 2025 | 237 |
| 2026 | 133 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"Breast Cancer Res"[Journal]
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
Meeting abstracts of the 11th International Breast Density and Cancer Risk Assessment Workshop : Līhu'e, HI, USA 4-6 June 2025.
- [No authors listed]
- Breast Cancer Res. 2026 Sep 10;28(Suppl 3):149. doi: 10.1186/s13058-026-02322-8.
- PMCID: PMC13560166
[No authors listed]Breast Cancer Res. 2026.PMCID: PMC13560166 -
British society of breast radiology annual scientific meeting abstracts.
- [No authors listed]
- Breast Cancer Res. 2026 May 25;28(Suppl 1):79. doi: 10.1186/s13058-026-02253-4.
- PMCID: PMC13200334
[No authors listed]Breast Cancer Res. 2026.PMCID: PMC13200334 -
Integrated multi-omics analysis and functional validation reveal the role of TRIM2 as a potential novel biomarker in breast cancer.
- Deng R, Ren Y, Hu K, Zhang Y, Xu Y, Zhang Q, Li Y, Huang X, Zhang F.
- Breast Cancer Res. 2026 Mar 31;28(1):84. doi: 10.1186/s13058-026-02263-2.
- PMCID: PMC13162474
Deng R, et al.Breast Cancer Res. 2026.PMCID: PMC13162474 -
Single-cell landscape of intratumoral heterogeneity and GABA-mediated remodeling of the immune microenvironment in breast cancer metastases.
- Tang L.
- Breast Cancer Res. 2026 Mar 31;28(1):85. doi: 10.1186/s13058-026-02268-x.
- PMCID: PMC13162450
Tang L.Breast Cancer Res. 2026.PMCID: PMC13162450 -
[225Ac]Ac-labeled matuzumab is an effective radioimmunotherapeutic against EGFR-positive triple negative breast cancer.
- Tikum AF, Fon DA, Njotu FN, Henning N, Nwangele E, Babeker H, Ketchemen JP, Doroudi A, Uppalapati M, Fonge H.
- Breast Cancer Res. 2026 Jan 16;28(1):44. doi: 10.1186/s13058-026-02220-z.
- PMCID: PMC12892558
Tikum AF, et al.Breast Cancer Res. 2026.PMCID: PMC12892558 -
Estrogen metabolism pathways in pregnancy and subsequent breast cancer risk: a prospective follow-up study.
- Troisi R, Falk RT, Surcel HM, Kauppila S, Mirtti T, Gissler M, Sampson J, Xu X, Fan S, Gierach GL.
- Breast Cancer Res. 2026 Jan 16;28(1):43. doi: 10.1186/s13058-025-02204-5.
- PMCID: PMC12892530
Troisi R, et al.Breast Cancer Res. 2026.PMCID: PMC12892530 -
CRYβB2 is a biomarker for poor prognosis and response to CDK4/6 inhibitors in breast cancer.
- Yan Y, Narayan A, Mazinani M, Saeki H, Huang T, Lofland G, Gabrielson E, Cope L, Kanaan YM, Afsari A, Naab T, Sukumar S, Pomper MG, Merino VF.
- Breast Cancer Res. 2026 Jan 14;28(1):42. doi: 10.1186/s13058-025-02188-2.
- PMCID: PMC12888483
Yan Y, et al.Breast Cancer Res. 2026.PMCID: PMC12888483 -
Subtype-specific health and economic impact of delayed breast cancer diagnosis during the early COVID-19 pandemic in Belgium: a Markov model analysis.
- Khan Y, Verhaeghe N, Monten C, Vanthomme K, Gadeyne S, Devleesschauwer B, Verdoodt F, Peacock HM, De Smedt D.
- Breast Cancer Res. 2025 Dec 28;28(1):41. doi: 10.1186/s13058-025-02207-2.
- PMCID: PMC12888680
Khan Y, et al.Breast Cancer Res. 2025.PMCID: PMC12888680 -
Characterization of ESR1 alterations in patients with breast and gynecologic cancers.
- Basu GD, Innis PE, Deem AK, Starodynov A, Udhane SS, Szelinger S, Wang M, LoBello JR, Baehner FL, De La O JP, O'Shaughnessy J.
- Breast Cancer Res. 2026 Jan 19;28(1):40. doi: 10.1186/s13058-025-02217-0.
- PMCID: PMC12879367
Basu GD, et al.Breast Cancer Res. 2026.PMCID: PMC12879367 -
Ultrasound-guided diffuse optical tomography: an adjunct to ultrasound that can reduce unnecessary breast biopsies.
- Zhu Q, Bennett D, Hagemann IS, Mannix J, Wiele K, Luther M, Luo J, Poplack SP.
- Breast Cancer Res. 2025 Dec 31;28(1):31. doi: 10.1186/s13058-025-02206-3.
- PMCID: PMC12865999
Zhu Q, et al.Breast Cancer Res. 2025.PMCID: PMC12865999